Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion type Assertion NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_head.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion description "[Mutated ERBB4 signaling activates both aberrant ERBB4 and PI3K-AKT signal transduction, mediates sensitivity to small-molecule inhibition with the dual-tyrosine kinase inhibitor lapatinib, and has recently also been implied in oncogenic glutamatergic signaling in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_provenance.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion evidence source_evidence_literature NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_provenance.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion SIO_000772 24258993 NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_provenance.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion wasDerivedFrom befree-2016 NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_provenance.
- NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_assertion wasGeneratedBy ECO_0000203 NP1130033.RAYOjbU3W-fM3_ZAcimGm9euBTWxPqC2o7FENju1yRcps130_provenance.